| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income (loss) | 251,412 | -718,470 | -92,541 | 215,055 |
| Basic (in dollars per share) | 4.14 | -11.74 | -1.52 | 3.5 |
| Diluted (in dollars per share) | 4.08 | -11.74 | -1.52 | 3.42 |
| Weighted-average ordinary shares used in per share calculations - basic (in shares) | 60,696,000 | 61,194,000 | 60,979,000 | 61,414,000 |
| Weighted-average ordinary shares used in per share calculations - diluted (in shares) | 61,606,000 | 61,194,000 | 60,979,000 | 63,174,000 |
Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc (JAZZ)